Combipul

Combipul

ipratropium bromide + salbutamol

Manufacturer:

Cipla

Distributor:

Phil Pharmawealth
Concise Prescribing Info
Contents
Per MDI Ipratropium Br 20 mcg, salbutamol sulfate 100 mcg. Per Nebule Ipratropium Br 500 mcg, salbutamol sulfate 2.5 mg
Indications/Uses
Acute asthmatic attacks & exacerbations of chronic bronchitis. Management of bronchospasm in COPD.
Dosage/Direction for Use
MDI Adult 1-2 actuations tid-qid. Childn 6-12 yr 1-2 actuations tid; <5 yr 1 actuation tid. Nebule Adult, elderly, adolescent >14 yr 1 unit nebulized qid, 3-14 yr 1 unit tid, 1 mth-2 yr 1/8-½ unit tid.
Special Precautions
Hepatic & renal insufficiency. Pregnancy & lactation.
Adverse Reactions
Tremor, nervousness, tachycardia, dizziness, headache, hypokalemia, dry mouth, throat irritation & urinary retention. Allergic-type & anaphylactic reactions.
Drug Interactions
Anticholinergic drugs, β-blocking adrenergic agents, diuretic, MAOIs or TCAs.
MIMS Class
Antiasthmatic & COPD Preparations
ATC Classification
R03AL02 - salbutamol and ipratropium bromide ; Belongs to the class of combination of adrenergics with anticholinergics, that may also include a corticosteroid. Used in the treatment of obstructive airway diseases.
Presentation/Packing
Form
Combipul MDI
Packing/Price
200 actuation x 1's
Form
Combipul nebules
Packing/Price
2.5 mL x 20 × 1's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in